Korro Bio, Inc.
KRRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $339,606 | $75,135 | $49,088 | $1,140,656 |
| - Cash | $55,643 | $166,150 | $36,333 | $83,492 |
| + Debt | $44,765 | $33,207 | $3,130 | $45,598 |
| Enterprise Value | $328,728 | -$57,808 | $15,885 | $1,102,762 |
| Revenue | $2,271 | $0 | $0 | $14,068 |
| % Growth | – | – | -100% | – |
| Gross Profit | $2,271 | $0 | $0 | $10,227 |
| % Margin | 100% | – | – | 72.7% |
| EBITDA | -$88,345 | -$80,904 | -$56,487 | -$80,066 |
| % Margin | -3,890.1% | – | – | -569.1% |
| Net Income | -$83,581 | -$81,172 | -$58,032 | -$84,686 |
| % Margin | -3,680.4% | – | – | -602% |
| EPS Diluted | -9.37 | -53.08 | -227.42 | -4.94 |
| % Growth | 82.3% | 76.7% | -4,503.6% | – |
| Operating Cash Flow | -$60,074 | -$67,283 | -$53,645 | -$32,094 |
| Capital Expenditures | -$17,902 | -$7,836 | -$5,212 | -$4,447 |
| Free Cash Flow | -$77,976 | -$75,119 | -$58,857 | -$36,541 |